Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-560-0 | CAS number: 18765-38-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Summary and discussion of toxicokinetics
There are no in vitro or in vivo data on the toxicokinetics of tetrakis(2-butoxyethyl) orthosilicate.
The following summary has therefore been prepared based on validated predictions of the physicochemical properties of the substance itself and its hydrolysis products and using this data in algorithms that are the basis of many computer-based physiologically based pharmacokinetic or toxicokinetic (PBTK) prediction models. Although these algorithms provide a numerical value, for the purposes of this summary only qualitative statements or comparisons will be made.
The main input variable for the majority of these algorithms is log Kow so by using this, and other where appropriate, other known or predicted physicochemical properties of tetrakis(2-butoxyethyl) orthosilicate reasonable predictions or statements may be made about its potential absorption, distribution, metabolism and excretion (ADME) properties.
Tetrakis(2-butoxyethyl) orthosilicate has a predicted water solubility of 6.6 mg/l, a predicted log Kow of 4.3 and a molecular weight of 496.8.
In contact with water, tetrakis(2-butoxyethyl) orthosilicate hydrolyses rapidly (half-life of approximately 4 hours at pH 7, 1.7 hours at pH 4, 1.7 hours at pH 9 and 20 -25°C) to generate monosilicic acid. Monosilicic acid undergoes reversible condensation reactions in water and a dynamic equilibrium is established. Above approximately 100 -150 mg/l as SiO2, an amorphous precipitate (polysilicic acid or SAS or insoluble silica) is formed. The solubility of monosilicic acid (soluble silica) in aqueous media is therefore limited to 100 -150 mg/l. It has a predicted log Kow of -4 and a molecular weight of 96.1.
The non-silanol product of hydrolysis is 2-butoxyethanol. 2 -butoxyethanol is miscible with water and has a log Kow of 0.8 and a molecular weight of 118.2.
Relevant human exposure is to the parent substance and can occur via the inhalation or dermal routes.
The toxicokinetics of 2-butoxyethanol have been reviewed in other major reviews (OECD SIDS, 1997) and are only considered briefly here to support the reduction of assessment factors in the DNEL derivation.
Absorption
Oral
Significant oral exposure is not expected for this substance.
When oral exposure takes place, it is necessary to assume that except for the most extreme of insoluble substances, that uptake through intestinal walls into the blood takes place. Uptake from intestines must be assumed to be possible for all substances that have appreciable solubility in water or lipid. Other mechanisms by which substances can be absorbed in the gastrointestinal tract include the passage of small water-soluble molecules (molecular weight up to around 200) through aqueous pores or carriage of such molecules across membranes with the bulk passage of water (Renwick, 1993).
Due to the molecular weight (497 g/mol) and low water solubility (6.6 mg/L) of tetrakis(2-butoxyethyl) orthosilicate should oral exposure occur significant systemic exposure to the parent substance is unlikely. The available physical chemical data indicates that tetrakis(butoxyethoxy)silane is rapidly hydrolysed in the stomach following oral exposure (at 37.5ºC and pH 2, the hydrolysis half -life is approximately 30 seconds). The non-silicon hydrolysis product, 2-butoxyethanol, has physicochemical properties favourable for absorption (moderate log Kow and high water solubility). 2 -Butoxyethanol is readily absorbed (100% assumed) following oral exposure (EU SCHER, 2008).
The physicochemical properties of monosilicic acid are less favourable for absorption (very log Kow, limited solubility in water). However, some monosilicic acid may be absorbed from the gut. Absorption of insoluble silica will be insignificant as compared to the absorption of the soluble species (Carlisle, 1986); the high molecular weight and lack of solubility of the condensed silica species make their absorption unfavourable.
The repeated dose toxicity study via the oral route (Eurofins (2016)) does show evidence of absorption, as systemic effects were observed.
Dermal
The fat solubility and therefore potential dermal penetration of a substance can be estimated by using the water solubility and log Kow values. Substances with log Kow values between 1 and 4 favour dermal absorption (values between 2 and 3 are optimal) particularly if water solubility is high.
Tetrakis(2-butoxyethyl) orthosilicate has a log Kow value (4.3) above the favourable range and low water solubility (6.6 mg/L) therefore absorption across the skin is not likely to occur and significant systemic exposure following dermal exposure is unlikely.
The hydrolysis product, 2-butoxyethanol is known to be well absorbed following dermal exposure (EU SCHER, 2008).
The silicon-containing hydrolysis product, silicic acid, does not have favourable properties for dermal absorption (very low log Kow, limited water solubility). The substance is likely to be too hydrophilic to cross the lipid rich environment of the stratum corneum.
Inhalation
There is a QSPR to estimate the blood:air partition coefficient for human subjects as published by Meulenberg and Vijverberg (2000). The resulting algorithm uses the dimensionless Henry coefficient and the octanol:air partition coefficient (Koct:air) as independent variables.
Using these values for tetrakis(2-butoxyethyl) orthosilicate results in a blood:air partition coefficient of approximately 36:1 meaning that if lung exposure occurred there would be some uptake into the systemic circulation. When monosilicic acid is produced by hydrolysis, it may be retained in the lining of the respiratory tract as it is very polar. Absorption is likely to be low. The low solubility of the parent (6.6 mg/l) and the relatively slow hydrolysis (t1/2 88 mins at pH 7 and 37.5) means that concentrations of silicic acid in the lung are unlikely to be high enough to result in formation of insoluble silica via condensation reactions (monosilicic acid is soluble to about 100-150 mg/l).
The hydrolysis product, 2 -butoxyethanol is known to be well absorbed following inhalation, with absorption of 55 -60% measured in human volunteer inhalation studies (EU SCHER, 2008). The physicochemical properties are favourable for uptake via the lungs.
Distribution
For blood:tissue partitioning a QSPR algorithm has been developed by De Jongh et al. (1997) in which the distribution of compounds between blood and human body tissues as a function of water and lipid content of tissues and the n-octanol:water partition coefficient (Kow) is described. Using this value for tetrakis(2-butoxyethyl) orthosilicate predicts that, should systemic exposure to parent occur, distribution would primarily be into fat, with potential slight distribution into liver, muscle, brain and kidney.
Table: tissue:blood partition coefficients
|
Log Kow |
Kow |
Liver |
Muscle |
Fat |
Brain |
Kidney |
tetrakis(2-butoxyethyl) orthosilicate |
4.3 |
19952 |
8.6 |
5.3 |
113.3 |
9.6 |
5.8 |
Tetrakis(2-butoxyethyl) orthosilicate which is absorbed may be expected to undergo hydrolysis within the blood.
Experimental animal studies have shown the hydrolysis product 2-butoxyethanol is rapidly and widely distributed to all tissues following oral and dermal exposure (OECD SIDS, 1997 - publications cited).
Silicic acid is a small molecule and therefore has the potential to be widely distributed but its hydrophilic nature will limit diffusion across membranes and accumulation in fatty tissues. Human blood contains 1 mg SiO2/l of monosilicic acid (Iler, R. K., 1979).
Metabolism
Data on the metabolism of tetrakis(2-butoxyethyl) orthosilicate are not available, but initial hydrolysis leads to the formation of the non-silanol hydrolysis product, 2-butoxyethanol and monosilicic acid. 2-Butoxyethanol is rapidly metabolised (plasma half-life of less than one hour) to form 2 -butoxy-acetic acid (BAA). This metabolsim is catalysed by alcohol dehydrogenase and aldehyde dehydrogenase and is followed by formation of glucuronide conjugates of BAA. A significant proportion of 2 -butoxyethanol remains unmetabolised (EU SCHER, 2008).
In animals, smaller amounts of the glucuronide and sulfate conjugates and ethylene glycol can be formed by other metabolic pathways, following exposure at high doses. In human studies, the glutamine conjugate of BAA has been detected in urine following exposure to 2-butoxyethanol, and suggests an additional detoxification pathway in humans (Rettenmeier et al., 1993 in OECD SIDS, 1997 - publication not found). Genetic toxicity tests in vitro showed no observable differences in effects with and without metabolic activation for tetrakis(2-butoxyethyl) orthosilicate.
Silicon is an essential trace element participating in the normal metabolism of higher animals. It is required in bone, cartilage and connective tissue formation as well as participating in other important metabolic processes. The silicon is present almost entirely as free, soluble monosilicic acid (Carlisle 1986).
Excretion
A determinant of the extent of urinary excretion is the soluble fraction in blood. QPSRs as developed by De Jonghet al. (1997) using log Kow as an input parameter, calculate the solubility in blood based on lipid fractions in the blood assuming that human blood contains 0.7% lipids.
Using the algorithm, the soluble fraction of tetrakis(2-butoxyethyl) orthosilicate in blood is <1% and is therefore unlikely to be eliminated via the kidneys in urine. In the available repeat dose toxicity studies, adverse effects including tubular hemosiderin deposits and tubulo-interstitial inflammation were noted in the kidneys. The main route of elimination of 2-butoxyethanol in experimental animals and humans is rapid excretion via the urine as BAA (80 to 90% as BAA). The plasma half-life of metabolites is four hours. About 10-20% of BAA is eliminated as CO2 in expired air (EU SCHER, 2008; OECD SIDS, 1997 - publication given).
There is a PBPK model for 2-butoxyethanol, which is sufficiently well developed to justify its used to derive animal to man toxicokinetic extrapolation factors for the inhalation route. These factors are based on the toxicokinetics of BAA since this is the metabolite that causes the critical toxic effects (EU Risk Assessment, 2008).
References
Renwick A. G. (1993) Data-derived safety factors for the evaluation of food additives and environmental contaminants.Fd. Addit. Contam.10: 275-305.
Meulenberg, C.J. and H.P. Vijverberg, Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. Toxicol Appl Pharmacol, 2000. 165(3): p. 206-16.
DeJongh, J., H.J. Verhaar, and J.L. Hermens, A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch Toxicol, 1997.72(1): p. 17-25.
EU Risk Assessment Report on 2 -butoxyethanol (EGBE), CAS 111 -76 -2, Human Health Part, 2008.
SCHER Opinion on the risk assessment report on the risk assessment report on 2 -butoxyethanol (EGBE), CAS 111 -76 -2, Human Health Part, 12 March 2008.
OECD (1997): SIDS Initial Assessment Report for SIAM 6, Paris, 9-11 June 1997,2-butoxyethanol, CAS 111-76-2.
Iler, Ralph K. (1979) The Chemistry of Silica: Solubility, Polymerization, Colloid and Surface Properties and Biochemistry of Silica, Wiley, p. 13.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.